HAE
HEALTHCAREHaemonetics Corporation
AI Insight
What's Moving HAE Today?
No stock-specific AI insight has been generated for HAE yet. Check back soon — insights are generated from recent news analysis.
52-Week Range
$47.32$87.32
$72.87
Fundamentals
Market Cap$3.3B
P/E Ratio35.5
EPS$2.05
Dividend Yield—
Dividend / Share—
ROE12.0%
Profit Margin7.3%
Debt / Equity—
Trading
Volume108K
Avg Volume (10D)—
Shares Outstanding45.4M
HAE News
24 articles- A Look At Haemonetics (HAE) Valuation After Its New Apheresis And MedSurg Segment RealignmentYahoo Finance·Jun 9, 2026
- Haemonetics (NYSE: HAE) VP settles RSU taxes with 259 withheld sharesStock Titan·Jun 9, 2026
- Sector Update: Healthcare Stocks Higher Late AfternoonYahoo Finance·Jun 5, 2026
- Haemonetics Updates Financial Reporting SegmentsYahoo Finance·Jun 5, 2026
- Haemonetics to Present at Goldman Sachs 47th Annual Global Healthcare ConferenceYahoo Finance·Jun 2, 2026
- HAE Maintained by Citigroup -- Price Target Raised to $70GuruFocus·May 28, 2026
- John Slump Launches Metis MedTech Following Atraverse Medical Acquisition by Johnson & JohnsonYahoo Finance·May 28, 2026
- Why Haemonetics (HAE) Is Up 14.3% After Earnings Beat And BofA Upgrade And What's NextYahoo Finance·May 25, 2026
- Haemonetics (HAE) Stock Is Up, What You Need To KnowYahoo Finance·May 23, 2026
- Haemonetics upgraded at BofA on conservative outlookMSN·May 23, 2026
- Medical Devices & Supplies - Specialty Stocks Q1 Highlights: Haemonetics (NYSE:HAE)Yahoo Finance·May 23, 2026
- Investing in Haemonetics (HAE)? Don't Miss Assessing Its International Revenue TrendsYahoo Finance·May 22, 2026
- Does Haemonetics (HAE) Have Enduring Growth Potential?Yahoo Finance·May 21, 2026
- 3 Russell 2000 Stocks That Concern UsYahoo Finance·May 20, 2026
- 3 Small-Cap Stocks We’re Skeptical OfYahoo Finance·May 19, 2026
- Is the Options Market Predicting a Spike in Haemonetics Stock?Yahoo Finance·May 13, 2026
- Americans Are Cutting Spending on Everything Except Healthcare. These 2 Medical Device Stocks Under $30 Are Built to Win247 Wall St·May 13, 2026
- A Look At Haemonetics (HAE) Valuation After Recent Share Price WeaknessYahoo Finance·May 12, 2026
- HAE Stock Gains on Q4 Earnings & Revenue Beat, Gross Margin CutYahoo Finance·May 11, 2026
- Haemonetics Q4 Earnings Call HighlightsMarketbeat·May 10, 2026
- Haemonetics (HAE) Q4 2026 Earnings TranscriptMotley Fool·May 8, 2026
- Haemonetics Corporation Q4 2026 Earnings Call SummaryMoby·May 8, 2026
- Haemonetics: Fiscal Q4 Earnings SnapshotWKYC·May 7, 2026
- Haemonetics (HAE) Reports Q4 Earnings: What Key Metrics Have to SayYahoo Finance·May 7, 2026
All 24 articles loaded
Price Data
Open$73.60
Previous Close$72.78
Day High$74.98
Day Low$72.29
52 Week High$87.32
52 Week Low$47.32
52-Week Range
$47.32$87.32
$72.87
Fundamentals
Market Cap$3.3B
P/E Ratio35.5
EPS$2.05
Dividend Yield—
Dividend / Share—
ROE12.0%
Profit Margin7.3%
Debt / Equity—
Trading
Volume108K
Avg Volume (10D)—
Shares Outstanding45.4M
About Haemonetics Corporation
Haemonetics Corporation, a healthcare company, offers medical products and solutions. The company is headquartered in Boston, Massachusetts.
HEALTHCAREMEDICAL DEVICES
Company Details
Security TypeCommon Stock
ExchangeNYSE
CurrencyUSD
Round Lot—
SICMEDICAL DEVICES
CIK—
Composite FIGI—
Share Class FIGI—